Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania

BACKGROUND: Controlled clinical trials have shown that a six-dose regimen of artemether-lumefantrine (AL) therapy for uncomplicated Plasmodium falciparum malaria results in cure rates >95% with good tolerability. MATERIALS AND METHODS: A prospective study was carried out to document the adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabanywanyi, Abdunoor M, Lengeler, Christian, Kasim, Prudensiana, King'eng'ena, Said, Schlienger, Raymond, Mulure, Nathan, Genton, Blaise
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833168/
https://www.ncbi.nlm.nih.gov/pubmed/20149235
http://dx.doi.org/10.1186/1475-2875-9-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833168/
https://www.ncbi.nlm.nih.gov/pubmed/20149235
http://dx.doi.org/10.1186/1475-2875-9-48

Ejemplares similares